Date Field | Doc. No. | Party | Description |
---|
Nov 16, 2015 | 22 | board | Decision - Denying Institution of Inter Partes Review - 37 CFR 42.108 Download |
Sep 25, 2015 | 21 | board | Decision - Denying Sanctions Motion - 37 C.F.R. 42.12 Download |
Sep 10, 2015 | 20 | patent_owner | Patent Owner Reply Motion for Sanctions Download |
Sep 2, 2015 | 1045 | petitioner | Hearing before the Subcommittee on Intellectual Property, Competition, and the Internet of the Committee on the Judiciary House of Representatives, March 10, 2011, Serial No. 112-20 Download |
Sep 2, 2015 | 1043 | petitioner | The Impact of Exempting the Pharmaceutical Industry from Patent Reviews Download |
Sep 2, 2015 | 1040 | petitioner | Dwivedi et al., Evergreening_A deceptive device in patent rights, 32 TECHNOLOGY IN SOCIETY, 324-330_2010 Download |
Sep 2, 2015 | 1041 | petitioner | Statement of the Federal Trade Commission, FTC v. Cephalon, Inc., May 28, 2015 Download |
Sep 2, 2015 | 1035 | petitioner | Information for Vermont Prescribers of Prescription Drugs re Pomalyst (pomalidomide) capsules Download |
Sep 2, 2015 | 18 | petitioner | Petitioner's Response in Opposition to Patent Owner Motion for Sanctions Download |
Sep 2, 2015 | 1048 | petitioner | Palmer, E., FDA Grants Celgenes Revlimid New Use, As It Moves Toward 10B in Sales, FIERCEPHARMA, February 19, 2015 Download |
Sep 2, 2015 | 1047 | petitioner | Shepard Report re Neumann v. Vidal, 710 F.2d 856, 228 U.S. App. D.C. 345, 1983 U.S. App. LEXIS 26562, 1983-1 Trade Cas.P65455_1983 Download |
Sep 2, 2015 | 1038 | petitioner | Complaint for Patent Infringement dated July 20, 2012 in Civil Action No. 12-04571 Download |
Sep 2, 2015 | 1044 | petitioner | Testimony of Professor Owen A. Lamont, June 28, 2006 Download |
Sep 2, 2015 | 1037 | petitioner | Second Amended Complaint for Patent Infringement dated March 25, 2011 in Civil Action No. 10-5197 Download |
Sep 2, 2015 | 19 | petitioner | Petitioner's Updated Exhibit List Download |
Sep 2, 2015 | 1034 | petitioner | Information for Vermont Prescribers of Prescription Drugs re Revlimid (lenalidomide) capsules Download |
Sep 2, 2015 | 1036 | petitioner | Orange Book_Approved Drug Products withTherapeutic Equivalence Evaluations_Patent No. 5,635,517 Download |
Sep 2, 2015 | 1046 | petitioner | Hearing before the Subcommittee on Intellectual Property, Competition, and the Internet of the Committee on the Judiciary House of Representatives, March 30, 2011, Serial No. 112-35 Download |
Sep 2, 2015 | 1039 | petitioner | To Promote Innovation_The Proper Balance of Competition and Patent Law and Policy Download |
Sep 2, 2015 | 1042 | petitioner | Pay-for-Delay_How Drug Company Pay-Offs Cost Consumers Billions, An FTC Staff Study, January 2010 Download |
Aug 19, 2015 | 2032 | patent_owner | Kalebic, Thea, et al. - Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine (1991) Download |
Aug 19, 2015 | 2073 | patent_owner | Law360 - Shire Drugs Are Next Targets of Hedge Funds AIA Reviews (2015) Download |
Aug 19, 2015 | 2004 | patent_owner | Jonsson, N. Ake - Chemical structure and teratogenic properties (1972) Download |
Aug 19, 2015 | 2016 | patent_owner | Larkin, S.W. et al. - Prolonged Microvascular Vasodilation Induced by Leukotriene B4 in Human Skin Is Cyclooxygenase Independent (1995) Download |
Aug 19, 2015 | 17 | patent_owner | Patent Owner Motion for Sanctions Download |
Aug 19, 2015 | 2055 | patent_owner | The Wall Street Journal - Innovate or Else, Kyle Bass Strikes Again and Challenges Shire Patents (2015) Download |
Aug 19, 2015 | 16 | patent_owner | Patent Owner Preliminary Response Download |
Aug 19, 2015 | 2048 | patent_owner | Selleckchem.com - Pomadlidomide Datasheet Download |
Aug 19, 2015 | 2020 | patent_owner | Page, Theresa et al. - Nonsteroidal Anti-Inflammatory Drugs Increase TNF Production in Rheumatoid Synovial Membrane Cultures and Whole Blood (2010) Download |
Aug 19, 2015 | 2059 | patent_owner | January 2014 Spangenberg/IPNav threatened 501 patent IPR declaration Download |
Aug 19, 2015 | 2066 | patent_owner | July 2014 IRDP threatened 501 patent IPR petition Download |
Aug 19, 2015 | 2062 | patent_owner | January 2014 Spangenberg/IPNav threatened 720 patent anticipation IPR petition Download |
Aug 19, 2015 | 2038 | patent_owner | Rordorf-Adam, C. et al, - CGP 47969A, A novel inhibitor of the synthesis of inflammatory cytokines (1994) Download |
Aug 19, 2015 | 2043 | patent_owner | King, Barry, et al. - Antiinflammatory-Immunosuppressive Thalidomide Analogs (1985) Download |
Aug 19, 2015 | 2002 | patent_owner | FDA website - About the FDA (2014) Download |
Aug 19, 2015 | 2015 | patent_owner | Bode-Boger, Stefanie, et al. - L-Arginine Induces Nitric Oxide-Dependent Vasodilation in Patients With Critical Limb Ischemia (1996) Download |
Aug 19, 2015 | 2003 | patent_owner | Smith, R.L. et al. - Studies on the Relationship Between the Chemical Structure and Embryotoxic Activity of Thalidomide and Related Compounds (1965) Download |
Aug 19, 2015 | 2060 | patent_owner | January 2014 Spangenberg/IPNav threatened 720 patent obviousness IPR petition Download |
Aug 19, 2015 | 2023 | patent_owner | Marie, C., et al. - Regulation by anti-inflammatory cytokines (IL-4, IL-IO, IL-13, TGF) of interleukin-8 production by LPS and/or TNFa-activated human polymorphonuclear cells (1996) Download |
Aug 19, 2015 | 2031 | patent_owner | Herbein, Georges, et al. - The macrophage in HIV-1 infection From activation to deactivation (2010) Download |
Aug 19, 2015 | 2005 | patent_owner | Powell, R.J. - New roles for thalidomide- A unique anti-inflammatory, but use it only when no alternatives exist (1996) Download |
Aug 19, 2015 | 2058 | patent_owner | January 2014 Spangenberg/IPNav threatened 501 patent IPR petition Download |
Aug 19, 2015 | 2017 | patent_owner | Bateman, Adrian - Flesh and Bones of Pathology (2009) Download |
Aug 19, 2015 | 2072 | patent_owner | July 2014 IRDP patent family tree Download |
Aug 19, 2015 | 2051 | patent_owner | Delaware Department of State, Division of Corporations - Coalition for Affordable Drugs VI LLC - Entity Details Download |
Aug 19, 2015 | 2075 | patent_owner | Reuters - U.S. hedge fund plans to take on big pharma over patents (2015) Download |
Aug 19, 2015 | 2069 | patent_owner | July 2014 IRDP threatened 720 patent obviousness IPR declaration Download |
Aug 19, 2015 | 2024 | patent_owner | Trepicchio, William, et al. - Recombinant Human IL-11 Attenuates the Inflammatory Response Cytokine Through Down-Regulation of Proinflammatory Release and Nitric Oxide Production (1996) Download |
Aug 19, 2015 | 2077 | patent_owner | IP Watchdog, Senator Coons - Patents Are about the American Dream (2015) Download |
Aug 19, 2015 | 2007 | patent_owner | 517 File History, Information Disclosure Citation (1997) Download |
Aug 19, 2015 | 2018 | patent_owner | Krishnamoorthy, Sriram - Inflammation and disease progression (2006) Download |
Aug 19, 2015 | 2028 | patent_owner | Hastings, R.C. et al. - Thalidomide analogs with potential activity in erythema nodosum leprosum (1979) Download |
Aug 19, 2015 | 2067 | patent_owner | July 2014 IRDP threatened 501 patent IPR declaration Download |
Aug 19, 2015 | 2042 | patent_owner | Hassan, Khairy, et al. - Antiinflammatory-Immunosuppressive Thalidomide Analogs (1981) Download |
Aug 19, 2015 | 2012 | patent_owner | Bedarida, Gabriella, et al. - Pharmacodynamics and Drug Action H1- and H2-hystamine receptor - mediated vasodilation varies with aging in humans (1995) Download |
Aug 19, 2015 | 2036 | patent_owner | Crutchley, David, et al. - Effects of Prostacyclin Analogs on the Synthesis of Tissue Factor, Tumor Necrosis Factor-a and Interleukin-1ß in Human Monocytic THP-1 Cells1 (1994) Download |
Aug 19, 2015 | 2034 | patent_owner | Sekut, L., et al. - Anti-inflammatory activity of salmeterol, down-regulation of cytokine production (1995) Download |
Aug 19, 2015 | 2068 | patent_owner | July 2014 IRDP threatened 720 patent obviousness IPR petition Download |
Aug 19, 2015 | 2046 | patent_owner | Committee on Amines - Aromatic Amines, An Assessment of the Biological and Environmental Effects (1981) Download |
Aug 19, 2015 | 2009 | patent_owner | Intentionally Left Blank Download |
Aug 19, 2015 | 2041 | patent_owner | Schmahl, H.J. et al. - Pharmacokinetics of the Teratogenic and Nonteratogenic Thalidomide Analogs EM 12 and Supidimide in the Rat and Marmoset Monkey (1987) Download |
Aug 19, 2015 | 2039 | patent_owner | Helm, F., et al. - Comparative Teratological Investigation of Compounds structurally and pharmacologically Related to Thalidomide (1981) Download |
Aug 19, 2015 | 2027 | patent_owner | Testimony of Defendants Expert Witness, Clayton H. Heathcock, Ph.D., Astrazeneca UK Limited et al. v. Watson Laboratories, Inc. et al. (2012) Download |
Aug 19, 2015 | 2064 | patent_owner | January 2014 Spangenberg/IPNav patent family tree Download |
Aug 19, 2015 | 2033 | patent_owner | Scifinder - Thalidomide Download |
Aug 19, 2015 | 2047 | patent_owner | Uetrecht, Jack - Reactivity and Possible Significance of Hydroxylamine and Nitroso Metabolites of Procainamide (1985) Download |
Aug 19, 2015 | 2052 | patent_owner | The Wall Street Journal - New Hedge Fund Strategy. Dispute the Patent, Short the Stock (2015) Download |
Aug 19, 2015 | 2037 | patent_owner | Olivera, D.L., et al. - Effects of pyridinyl imidazole compounds on murine TNF-a production (1993) Download |
Aug 19, 2015 | 2019 | patent_owner | Bouwmeester, Tewis et al. - A physical and functional map of the human TNF-aNF-¿B signal transduction pathway (2004) Download |
Aug 19, 2015 | 2029 | patent_owner | Hastings, Robert - Kellersberger Memorial Lecture 1979 Immunosuppressive Anti-Inflammatory Thalidomide Analogues (1980) Download |
Aug 19, 2015 | 2006 | patent_owner | 517 File History, Notice of References Cited (1997) Download |
Aug 19, 2015 | 15 | patent_owner | Patent Owner Exhibit List Download |
Aug 19, 2015 | 2025 | patent_owner | Patrick, Graham - Drug Development (1995) Download |
Aug 19, 2015 | 2013 | patent_owner | Van Nueten, J.M., et al. - Serotonin and Vascular Reactivity (1985) Download |
Aug 19, 2015 | 2070 | patent_owner | July 2014 IRDP threatened 720 patent anticipation IPR petition Download |
Aug 19, 2015 | 2010 | patent_owner | Janeway, Charles, et al. - Immuno Biology 5, The Immune System in Health and Diseases (2001) Download |
Aug 19, 2015 | 2061 | patent_owner | January 2014 Spangenberg/IPNav threatened 720 patent obviousness IPR declaration Download |
Aug 19, 2015 | 2044 | patent_owner | Sheskin, J., et al. - Trials with Thalidomide Derivatives in Leprosy Reactions (1968) Download |
Aug 19, 2015 | 2040 | patent_owner | Barnhill, Raymond, et al. - Thalidomide, Use and possible mode of action in reactional lepromatous leprosy and in various other conditions (1982) Download |
Aug 19, 2015 | 2053 | patent_owner | Business Insider - Hedge Fund Manager Kyle Bass Is Going After Big Pharma And Its BS Patents (2015) Download |
Aug 19, 2015 | 2021 | patent_owner | Vane, J.R., et al. - Mechanism of Action of Anti-Inflammatory Drugs (1996) Download |
Aug 19, 2015 | 2022 | patent_owner | Kurumbail, G., et al. - Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents (1996) Download |
Aug 19, 2015 | 2030 | patent_owner | Henderson, Andrew, et al. - C-EBP Activators Are Required for HIV-1 Replication and Proviral Induction in Monocytic Cell Lines (1996) Download |
Aug 19, 2015 | 2035 | patent_owner | Smith, Carla, et al. - Cyclosporin a Blocks Induction of Tumor Necrosis Factor-Alpha in Human B Lymphocytes (1994) Download |
Aug 19, 2015 | 2056 | patent_owner | Dallas Observer Dallas Erich Spangenberg is Very Proud to be Americas Biggest Patent Troll (2013) Download |
Aug 19, 2015 | 2008 | patent_owner | U.S. Patent No. 5,712,291 (1998) Download |
Aug 19, 2015 | 2050 | patent_owner | Delaware Department of State, Division of Corporations - Coalition for Affordable Drugs Download |
Aug 19, 2015 | 2057 | patent_owner | January 2014 Spangenberg/IPNav email threatening IPRs Download |
Aug 19, 2015 | 2026 | patent_owner | Partial Testimony of Dr. Clayton Heathcock, Ph.D., In Re OxyContin Antitrust Litigation (2013) Download |
Aug 19, 2015 | 2054 | patent_owner | Hayman Capital Management, L.P. June 2015 Form ADV Part 2A Brochure Download |
Aug 19, 2015 | 2045 | patent_owner | Bruns, Robert, et al. - Rules for Identifying Potentially Reactive or Promiscuous Compounds (2012) Download |
Aug 19, 2015 | 2065 | patent_owner | July 2014 IRDP email threatening IPRs Download |
Aug 19, 2015 | 2071 | patent_owner | July 2014 IRDP threatened 720 patent anticipation IPR declaration Download |
Aug 19, 2015 | 2014 | patent_owner | Swartz, Stephen - The Role of Prostaglandins in Mediating the Effects of Angiotensin Converting Enzyme Inhibitors and Other Antihypertensive Drugs (1987) Download |
Aug 19, 2015 | 2076 | patent_owner | Pharma, The Catalyst - What They Are Saying, Close Patent Loopholes That Threaten Innovation for Patients (2015) Download |
Aug 19, 2015 | 2063 | patent_owner | January 2014 Spangenberg/IPNav threatened 720 patent anticipation IPR declaration Download |
Aug 19, 2015 | 2074 | patent_owner | Hayman Capital Management, L.P. - Statement of J. Kyle Bass Chief Investment Officer, Hayman Capital Management, L.P. (2015). Download |
Aug 19, 2015 | 2011 | patent_owner | Medzhitov, Ruslan - Origin and physiological roles of inflammation (2008) Download |
Aug 19, 2015 | 2049 | patent_owner | Pomalyst July 2014 Product Information Download |
Aug 19, 2015 | 2001 | patent_owner | Dr. V. Pannikar, WHO, - The Return of Thalidomide New Uses and Renewed Concerns Download |
Jul 21, 2015 | 14 | board | Order Authorizing Patent Owner's Motion for Sanctions Download |
Jul 20, 2015 | 10 | petitioner | Certificate of Service Download |
Jul 20, 2015 | 1032 | petitioner | Declaration of Brent E. Routman in Support of Motion for Admission Pro Hac Vice Download |
Jul 20, 2015 | 13 | petitioner | Certificate of Service Download |
Jul 20, 2015 | 1033 | petitioner | Declaration of Ryan J. Fletcher in Support of Motion for Admission Pro Hac Vice Download |
Jul 20, 2015 | 11 | petitioner | Petitioner's Motion for Admission Pro Hac Vice of Ryan J. Fletcher Download |
Jul 20, 2015 | 8 | petitioner | Petitioner's Motion for Admission Pro Hac Vice of Brent E. Routman Download |
Jul 20, 2015 | 9 | petitioner | Petitioner's Updated Exhibit List Download |
Jul 20, 2015 | 12 | petitioner | Petitioner's Updated Exhibit List Download |
May 28, 2015 | 5 | potential_po | Power of Attorney Download |
May 28, 2015 | 6 | potential_po | Power of Attorney Download |
May 28, 2015 | 7 | potential_po | Related Matters Download |
May 19, 2015 | 4 | board | Notice of Filing Date Accorded to Petition Download |
May 7, 2015 | 1011 | petitioner | U.S. Patent No. 5,635,517 File History_Application for Extension of Patent Term Download |
May 7, 2015 | 1016 | petitioner | U.S. Patent No. 5,593,990 Download |
May 7, 2015 | 1007 | petitioner | Declaration of Clayton H. Heathcock, Ph.D. Download |
May 7, 2015 | 1024 | petitioner | U.S. Patent No. 5,635,517 File History_Notice of Intent to Issue Reexamination Certificate Download |
May 7, 2015 | 1004 | petitioner | Agrawal et al., Structure activity relationship studies of thalidomide analogs as anti-inflammatory and immunosuppressive agents Download |
May 7, 2015 | 1026 | petitioner | DAmato et al., Thalidomide is an Inhibitor of Angiogenesis Download |
May 7, 2015 | 1012 | petitioner | U.S. Patent No. 5,635,517 File History_Original Application Download |
May 7, 2015 | 1005 | petitioner | WO 9420085 to DAmato Download |
May 7, 2015 | 1022 | petitioner | U.S. Patent No. 5,635,517 File History_Patent Owner Statement Download |
May 7, 2015 | 1014 | petitioner | U.S. Patent No. 5,635,517 File History_Interview Summary Download |
May 7, 2015 | 1025 | petitioner | U.S. Patent No. 5,635,517 Reexamination Certificate Download |
May 7, 2015 | 1030 | petitioner | Schumacher et al., The teratogenic activity of a thalidomide analogue, EM 12, in rabbits, rats, and monkeys Download |
May 7, 2015 | 1031 | petitioner | Sekut et al., Evaluation of the Significance of Elevated Levels of Systemic and Localized Tumor Necrosis Factor in Different Animal Models of Inflammation Download |
May 7, 2015 | 1029 | petitioner | Engelhardt et al., Pomalidomide, Recent Results Cancer Res. Download |
May 7, 2015 | 1028 | petitioner | Thalidomide and Congeners as Anti-inflammatory Agents Download |
May 7, 2015 | 1021 | petitioner | U.S. Patent No. 5,635,517 File History_Request for Reconsideration Download |
May 7, 2015 | 1002 | petitioner | Piper et al., Anti-inflammatory immunosuppressive thalidomide analogs_International Journal of Leprosy Download |
May 7, 2015 | 1008 | petitioner | Curriculum Vitae of Clayton H. Heathcock, Ph.D. Download |
May 7, 2015 | 1017 | petitioner | U.S. Patent No. 4,808,402 Download |
May 7, 2015 | 1010 | petitioner | Carswell et al., An Endotoxin-Induced Serum Factor that Causes Necrosis of Tumors Download |
May 7, 2015 | 1009 | petitioner | Sampaio et al., Thalidomide Selectively Inhibits Tumor Necrosis Factor_Production by Stimulated Human Monocytes Download |
May 7, 2015 | 2 | petitioner | Petitioner's Exhibit List Download |
May 7, 2015 | 1 | petitioner | Petition for Inter Partes Review of Patent No. 5,635,517 Download |
May 7, 2015 | 1006 | petitioner | KEITH WALTERS, NATIONAL TOXICOLOGY PROGRAM'S CHEMICAL SOLUBILITY COMPENDIUM Download |
May 7, 2015 | 1001 | petitioner | U.S. Patent No. 5,635,517 Download |
May 7, 2015 | 1013 | petitioner | U.S. Patent No. 5,635,517 File History_Notice of Allowance Download |
May 7, 2015 | 1019 | petitioner | U.S. Patent No. 5,635,517 File History_Order Granting Request for Reexamination Download |
May 7, 2015 | 3 | petitioner | Power of Attorney Download |
May 7, 2015 | 1015 | petitioner | U.S. Patent No. 5,635,517 File History_Request for Ex Parte Reexamination Download |
May 7, 2015 | 1023 | petitioner | U.S. Patent No. 5,635,517 File History_Declaration of David I. Stirling, Ph.D. Download |
May 7, 2015 | 1020 | petitioner | U.S. Patent No. 5,635,517 File History_Office Action in Reexamination Download |
May 7, 2015 | 1027 | petitioner | Koch, The Arene Oxide Hypothesis of Thalidomide Action. Download |
May 7, 2015 | 1003 | petitioner | U.S. Patent No. 5,385,901 Download |
May 7, 2015 | 1018 | petitioner | Leibovich et al., Macrophage-induced angiogenesis is mediated by tumor necrosis factor-alpha Download |